Coreg-cr-chem-struc (Carvedilol Phosphate Extended Release Spl Graphic 01)
Carvedilol Phosphate
Product Images NDC 60505-4715
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Carvedilol Phosphate (NDC 60505-4715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 Survival Analysis For Copernicus (intent To Treat) (Carvedilol Phosphate Extended Release Spl Graphic 02)
Figure 2. Effects On Mortality For Subgroups In Copernicus (Carvedilol Phosphate Extended Release Spl Graphic 03)
This appears to be a table or chart with various categories and subcategories listed, but it is not a complete or readable text. Therefore, the useful description cannot be generated.*
Figure 3 (Carvedilol Phosphate Extended Release Spl Graphic 04)
Figure 4. Effects On Mortality For Subgroups In Capricorn (Carvedilol Phosphate Extended Release Spl Graphic 05)
Figure 5. Changes From Baseline In Systolic Blood Pressure And Diastolic Blood Pressure Measured By 24-hour Abpm With Carvedilol Phosphate Extended-release Capsules (Carvedilol Phosphate Extended Release Spl Graphic 06)
Carvedilol Phosphate Er 10mg Capsule 30 Count Label (Carvedilol Phosphate Extended Release Spl Graphic 07)
This is a medication information for Carvedilol Phosphate Extended-release capsules, with 10mg strength. It is stored at 25° Celsius and comes in capsules that are different in strength from the tablets. The usual dosage is not provided, but you can check the prescribing information for complete dosing information. The drug should be kept out of reach of children and in case of accidental overdose, professional help should be sought immediately. It is manufactured for Apotex Corp, Weston, FL 33326 and made in Canada.*
Carvedilol Phosphate Er 20mg Capsule 30 Count Label (Carvedilol Phosphate Extended Release Spl Graphic 08)
Eachexencedrekase 30 Capsules is a medication containing 20 mg of Carvedilol phosphate. It is an extended-release capsule used for once-a-day dosing. The medication is developed by Apotex Corp and should be stored at 25°C (77°F). For more information on usage and dosage, refer to the prescribing information. Made in Canada.*
Carvedilol Phosphate Er 40mg Capsule 30 Count Label (Carvedilol Phosphate Extended Release Spl Graphic 09)
Carvedilol Phosphate Extended-release Capsules are a medication used for heart failure and high blood pressure treatment. Each capsule contains 40mg of carvedilol phosphate and should be stored at 25°C. It is essential not to accept the medication if the membrane seal under the cap is missing or broken, and it is advisable to keep it out of the reach of children. The usual dosage should be obtained from the prescribing information for complete dosing. In case of accidental overdose, professional help should be sought or contact the poison control center immediately. It is formulated differently in strength from carvedilol tablets. The manufacturer is Apotex Corp for the US market and made by GlaxoSmithKline.*
Carvedilol Phosphate Er 80mg Capsule 30 Count Label (Carvedilol Phosphate Extended Release Spl Graphic 10)
This is a description of a medication called "Carvedilol Phosphate Extended-Release Capsules." Each capsule contains a certain amount of carvedilol phosphate and must be stored at a temperature of 25°C (77°F). This medication is manufactured by "Glasnithline" and is intended for use by "Agotex Cor, Phosphate." It is important to keep this medication out of the reach of children and to seek professional medical attention if an accidental overdose occurs. The dosage information is available in the prescribing information. This is an extended-release capsule, different from the strength provided by carvedilol tablets. The item is available in packages containing 30 capsules and has an NDC number of 60505-3681-3.*
Carvedilol Phosphate Extended Release Spl Graphic 11
This appears to be the label of a medication called Carvedilol Phosphate. It comes in a size of 30 capsules and has an NDC (National Drug Code) number of 60505-4713-3. The capsules are extended-release and the dosage is recommended to be once a day. There is also a warning about overdose and seeking professional help. However, some text is not readable and the context is incomplete.*
Carvedilol Phosphate Extended Release Spl Graphic 12
Carvedilol Phosphate Extended Release Spl Graphic 13
Gawetoken is a medication available in the form of extended-release capsules. Each package contains 30 capsules and the product code is NDC 60505-4715-3. The medicine may contain Ovl Phosphate and Carvedilol Phosphate, and it is intended for once-a-day dosing. The rest of the text is either not-available or unclear due to errors.*
Carvedilol Phosphate Extended Release Spl Graphic 14
This is information related to medication named Carvedilol. It is an extended-release capsule medication and comes in a packet of 30 capsules. The medication is available in the strength of 80 mg and has once-a-day dosing. The NDC (National Drug Code) of the medication is 60505-4716-3. There are some storage instructions but they are not legible. The manufacturer of the medication is Apotex Corp.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
